As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration providing a better understanding of the future of direct (non-oral) treatments for bladder and Urinary Tract Infections (UTI). What does this mean?
From a clinical perspective this is a shift in quality of life for the patient and substantially better safety and efficacy.
From a marketing perspective this form of treatment opens many new opportunities in bladder treatments.
See the full research article here: Pathogens | Free Full-Text | Effective Treatments of UTI—Is Intravesical Therapy the Future? (mdpi.com)
Download the PDF article here: